These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 35563253)

  • 21. Microbiota-gut-brain axis in the Alzheimer's disease pathology - an overview.
    Giridharan VV; Barichello De Quevedo CE; Petronilho F
    Neurosci Res; 2022 Aug; 181():17-21. PubMed ID: 35577241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target.
    Liu S; Gao J; Liu K; Zhang HL
    Mech Ageing Dev; 2021 Oct; 199():111560. PubMed ID: 34411603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota and Alzheimer's Disease: How to Study and Apply Their Relationship.
    Nguyen NM; Cho J; Lee C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
    Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
    Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
    Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.
    Uddin MS; Al Mamun A; Kabir MT; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):281-303. PubMed ID: 32935230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationalizing therapeutic approaches in Alzheimer's disease.
    Grossberg GT
    CNS Spectr; 2005 Nov; 10(11 Suppl 18):17-21. PubMed ID: 16273026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
    Daily JW; Kang S; Park S
    Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA; Wenk GL
    CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advanced dementia in Alzheimer's disease and memantine].
    Alberca R
    Rev Neurol; 2005 Feb 1-15; 40(3):173-9. PubMed ID: 15750904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Acetylcholine Esterase Inhibitors and Memantine, Clinically Approved for Alzheimer's Dementia Treatment, on Intestinal Properties of the Mouse.
    Nguyen VTT; Sallbach J; Dos Santos Guilherme M; Endres K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy.
    Kabir MT; Sufian MA; Uddin MS; Begum MM; Akhter S; Islam A; Mathew B; Islam MS; Amran MS; Md Ashraf G
    Curr Pharm Des; 2019; 25(33):3506-3518. PubMed ID: 31604413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.